It is of note, that pharmacological inhibition of ATX activity per os triggered a positive feedback regulation that induced the expression of ATX in tumour cells and consequently failed to prevent tumour growth while the combined targeting of p190RhoGAP and p110δ PI3K blocked tumour growth by suppressing the expression of ATX without triggering this feedback mechanism. This evidence concerns the gene ARHGAP35 and neoplasm.